Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3TDN2

Entry ID Method Resolution Chain Position Source
AF-Q3TDN2-F1 Predicted AlphaFoldDB

30 variants for Q3TDN2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389284339 36 L>M No EVA
rs3389280413 47 V>I No EVA
rs3389284314 72 N>S No EVA
rs3389285776 76 H>Q No EVA
rs3389285775 87 Q>* No EVA
rs3413069134 119 R>C No EVA
rs3389283237 121 I>L No EVA
rs3389241536 135 D>V No EVA
rs3389283304 139 F>I No EVA
rs3389277024 146 K>T No EVA
rs3389292361 147 Y>* No EVA
rs3389283230 162 A>T No EVA
rs3389286338 167 K>R No EVA
rs3389286381 199 I>F No EVA
rs3404202816 209 W>* No EVA
rs3389286356 209 W>R No EVA
rs3389285765 224 A>G No EVA
rs3389285746 239 K>E No EVA
rs3389241535 241 R>Q No EVA
rs3389285759 262 L>V No EVA
rs3389292321 282 E>K No EVA
rs3389295211 369 P>R No EVA
rs3389267969 379 H>L No EVA
rs3389252604 379 H>N No EVA
rs3389292355 394 L>F No EVA
rs3389213676 409 R>I No EVA
rs3389277084 413 P>T No EVA
rs3389283269 420 W>C No EVA
rs3389295191 426 L>V No EVA
rs3404208284 443 T>I No EVA

No associated diseases with Q3TDN2

2 regional properties for Q3TDN2

Type Name Position InterPro Accession
domain UBX domain 357 - 440 IPR001012
domain UAS 138 - 263 IPR006577

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Lipid droplet
  • Endoplasmic reticulum
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
lipid droplet An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
VCP-NPL4-UFD1 AAA ATPase complex A multiprotein ATPase complex required for the efficient dislocation of ER-lumenal degradation substrates, and their subsequent proteolysis by the proteasome. In budding yeast, this complex includes Cdc48p, Npl4p and Ufd1p proteins. In mammals, this complex includes a hexamer of VCP/p97 (a cytosolic ATPase) and trimers of each of its cofactors UFD1L and NPL4 (NPLOC4) (e.g. a 6:3:3 stoichiometry).

4 GO annotations of molecular function

Name Definition
lipase binding Binding to a lipase.
lipase inhibitor activity Binds to and stops, prevents or reduces the activity of a lipase, an enzyme that catalyzes of the hydrolysis of a lipid.
ubiquitin binding Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.

5 GO annotations of biological process

Name Definition
lipid droplet organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lipid particle.
proteasome-mediated ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
response to unfolded protein Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
retrograde protein transport, ER to cytosol The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.
ubiquitin-dependent ERAD pathway The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q04228 UBX2 UBX domain-containing protein 2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q12229 UBX3 UBX domain-containing protein 3 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q96CS3 FAF2 FAS-associated factor 2 Homo sapiens (Human) PR
10 20 30 40 50 60
MAAPEEQDLT QEQTEKLLQF QDLTGIESME QCRLALEQHN WNMEAAVQDR LNEQEGVPSV
70 80 90 100 110 120
FNPPPARPLQ VNTADHRIYS YVVSRPQPRG LLGWGYYLIM LPFRFTYYTI LDIFRFALRF
130 140 150 160 170 180
IRPDPRSRVT DPVGDIVSFM HSFEEKYGRA HPVFYQGTYS QALNDAKREL RFLLVYLHGD
190 200 210 220 230 240
DHQDSDEFCR NALCAPEVIS LINSRMLFWA CSTNKPEGYR VSQALRENTY PFLAMIMLKD
250 260 270 280 290 300
RRMTVVGRLE GLIQPDDLIN QLTFIMDANQ TYLVSERLER EERNQTQVLR QQQDEAYLAS
310 320 330 340 350 360
LRADQEKERK KREEKERKRR KEEEVQQQKL AEERRRQNLQ EEKERKLECL PPEPSPDDPE
370 380 390 400 410 420
SVKIIFKLPN DSRVERRFHF SQSLTVIHDF LFSLKESPEK FQIEANFPRR VLPCVPSEEW
430 440
PNPPTLQEAG LSHTEVLFVQ DLTDE